Your browser doesn't support javascript.
loading
Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study.
Do, Young Rok; Choi, Yunsuk; Heo, Mi Hwa; Kim, Jin Seok; Yoon, Jae-Ho; Lee, Je-Hwan; Park, Joon Seong; Sohn, Sang Kyun; Kim, Sung Hyun; Lim, Sungnam; Chung, Joo Seop; Jo, Deog-Yeon; Eom, Hyeon Seok; Kim, Hawk; Jeon, So Yeon; Won, Jong-Ho; Lee, Hee Jeong; Shin, Jung Won; Jang, Jun-Ho; Yoon, Sung-Soo.
Afiliación
  • Do YR; Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
  • Choi Y; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Heo MH; Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
  • Kim JS; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Yoon JH; Division of Hematology, Department of Internal Medicine, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park JS; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.
  • Sohn SK; Department of Oncology/Hematology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea.
  • Kim SH; Division of Hematology and Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
  • Lim S; Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea.
  • Chung JS; Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Jo DY; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
  • Eom HS; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea.
  • Kim H; Division of Hematology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Jeon SY; Division of Hematology/Oncology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea.
  • Won JH; Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea.
  • Lee HJ; Department of Internal Medicine, Hemato-Oncology, Chosun University Hospital, Gwangju, Korea.
  • Shin JW; Division of Hematology/Oncology, Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Jang JH; Samsung Medical Center, Seoul National University College of Medicine, Seoul, Korea.
  • Yoon SS; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Blood Res ; 57(3): 207-215, 2022 Sep 30.
Article en En | MEDLINE | ID: mdl-35880496
ABSTRACT

Background:

Gaucher disease (GD) is an autosomal recessive disorder characterized by excessive accumulation of glucosylceramide in multiple organs. This study was performed to determine the detection rate of GD in a selected patient population with unexplained splenomegaly in Korea.

Methods:

This was a multicenter, observational study conducted at 18 sites in Korea between December 2016 and February 2020. Adult patients with unexplained splenomegaly were enrolled and tested for ß-glucosidase enzyme activity on dried blood spots (DBS) and in peripheral blood leukocytes. Mutation analysis was performed if the test was positive or indeterminate for the enzyme assay. The primary endpoint was the percentage of patients with GD in patients with unexplained splenomegaly.

Results:

A total of 352 patients were enrolled in this study (male patients, 199; mean age, 48.42 yr). Amongst them, 14.77% of patients had concomitant hepatomegaly. The most common sign related to GD was splenomegaly (100%), followed by thrombocytopenia (44.32%) and, anemia (40.91%). The ß-glucosidase activity assay on DBS and peripheral leukocytes showed abnormal results in sixteen and six patients, respectively. Eight patients were tested for the mutation, seven of whom were negative and one patient showed a positive mutation analysis result. One female patient who presented with splenomegaly and thrombocytopenia was diagnosed with type 1 GD. The detection rate of GD was 0.2841% (exact 95% CI, 0.0072‒1.5726).

Conclusion:

The detection rate of GD in probable high-risk patients in Korea was lower than expected. However, the role of hemato-oncologists is still important in the diagnosis of GD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Screening_studies Idioma: En Revista: Blood Res Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Screening_studies Idioma: En Revista: Blood Res Año: 2022 Tipo del documento: Article